A study of 64 patients indicates Naniprus is a highly-effective drug f
or control left ventricular failure. Intravenous administration of nan
iprus (15-30 mg 2 times daily) is effective in the orophylaxis of recu
rrences of leftventricular failure in patients with myocardial infarct
ion.